| |
Latest 10 SEC filings (by transaction date) for GRTS within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Feb 5/24 | Feb 1/24 | Hawryluk Matthew | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 180,000 | |
Feb 5/24 | Feb 1/24 | Hawryluk Matthew | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 35,000 | |
Feb 5/24 | Feb 1/24 | Jones Erin | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 235,000 | |
Feb 5/24 | Feb 1/24 | Jones Erin | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 40,000 | |
Feb 5/24 | Feb 1/24 | Economides Vassiliki | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 215,000 | |
Feb 5/24 | Feb 1/24 | Economides Vassiliki | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 35,000 | |
Feb 5/24 | Feb 1/24 | Jooss Karin | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 235,000 | |
Feb 5/24 | Feb 1/24 | Jooss Karin | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 40,000 | |
Feb 5/24 | Feb 1/24 | Cho James | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 109,000 | |
Feb 5/24 | Feb 1/24 | Cho James | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 18,000 | |
Sign up or login above to see all SEC filings within the past 6 months. |
Latest 10 SEC filings (by filing date) for GRTS within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Feb 5/24 | Feb 1/24 | Hawryluk Matthew | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 180,000 | |
Feb 5/24 | Feb 1/24 | Hawryluk Matthew | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 35,000 | |
Feb 5/24 | Feb 1/24 | Jones Erin | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 235,000 | |
Feb 5/24 | Feb 1/24 | Jones Erin | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 40,000 | |
Feb 5/24 | Feb 1/24 | Economides Vassiliki | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 215,000 | |
Feb 5/24 | Feb 1/24 | Economides Vassiliki | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 35,000 | |
Feb 5/24 | Feb 1/24 | Jooss Karin | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 235,000 | |
Feb 5/24 | Feb 1/24 | Jooss Karin | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 40,000 | |
Feb 5/24 | Feb 1/24 | Cho James | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 109,000 | |
Feb 5/24 | Feb 1/24 | Cho James | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 18,000 | |
Sign up or login above to see all SEC filings within the past 6 months. |
Sign up or login above to see the past 6 months of filings sorted by insider. . |
Competitors with Recent Insider Filings |
Intra-Cellular Therapies (OQ:ITCI) |
Apellis Pharmaceuticals (OQ:APLS) |
Biomarin Pharmaceutical (OQ:BMRN) |